Australian Industry Rejects Planned Tendering System For Off-Patent Drugs
Executive Summary
Plans to introduce a tendering system for off-patent medicines have been sharply criticized by originator and generic industry bodies in Australia, but proposals for a fully operational electronic prescribing and health record system have met with a warmer reception.